These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 39323011)

  • 1. Transitions of Care Pharmacist Impact Following Hospitalization for Acute Myocardial Infarction.
    Augustine MS; Roberts O; Sarubbi C; Toler JA; Gharkholonarehe N
    Ann Pharmacother; 2024 Sep; ():10600280241278791. PubMed ID: 39323011
    [No Abstract]   [Full Text] [Related]  

  • 2. Implementation and Effect of a Pharmacist-to-Pharmacist Transitions of Care Initiative on Ambulatory Care Sensitive Conditions.
    McFarland MS; Thomas AM; Young E; Bryant C; Hughes JC; Hoffman J; Baker JW
    J Manag Care Spec Pharm; 2020 Apr; 26(4):513-519. PubMed ID: 32223605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Real-world evidence on impact of a pharmacist-led transitional care program on 30- and 90-day readmissions after acute care episodes.
    Bae-Shaaw YH; Eom H; Chun RF; Steven Fox D
    Am J Health Syst Pharm; 2020 Mar; 77(7):535-545. PubMed ID: 32086512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacist Transition-of-Care Services Improve Patient Satisfaction and Decrease Hospital Readmissions.
    March KL; Peters MJ; Finch CK; Roberts LA; McLean KM; Covert AM; Twilla JD
    J Pharm Pract; 2022 Feb; 35(1):86-93. PubMed ID: 32945206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Community pharmacy transition of care services and rural hospital readmissions: A case study.
    Patton AP; Liu Y; Hartwig DM; May JR; Moon J; Stoner SC; Guthrie KD
    J Am Pharm Assoc (2003); 2017; 57(3S):S252-S258.e3. PubMed ID: 28412054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluating the effects of a multidisciplinary transition care management program on hospital readmissions.
    Snyder ME; Krekeler CE; Jaynes HA; Davis HB; Lantaff WM; Shan M; Perkins SM; Zillich AJ
    Am J Health Syst Pharm; 2020 Jun; 77(12):931-937. PubMed ID: 32436574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Pharmacist-Driven Transitions of Care Interventions on Post-hospital Outcomes Among Patients With Coronary Artery Disease: A Systematic Review.
    Weeda E; Gilbert RE; Kolo SJ; Haney JS; Hazard LT; Taber DJ; Axon RN
    J Pharm Pract; 2023 Jun; 36(3):668-678. PubMed ID: 34962844
    [No Abstract]   [Full Text] [Related]  

  • 8. Impact of a pharmacist-driven transitions of care clinic for a multisite integrated delivery network.
    Parodi M; Feeley B; Sanchez M
    Am J Health Syst Pharm; 2022 May; 79(11):844-851. PubMed ID: 35084448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diabetes Care in A Safety Net Hospital: Impact of a Pharmacist Transitional Care Service.
    Murray SM; Traynor LM; Carli L; Rhodes H; Brigino AM; Wikelius RM
    J Pharm Pract; 2024 May; ():8971900241256776. PubMed ID: 38789106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of a multidisciplinary approach to reduce internal medicine readmissions using a readmission prediction index.
    McConachie SM; Raub JN; Yost R; Monday L; Agrawal S; Tannous P
    Am J Health Syst Pharm; 2020 Jun; 77(12):950-957. PubMed ID: 32382749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of Pharmacist Medication Education and Post-discharge Follow-up in Reducing Readmissions in Patients With ST-Segment Elevation Myocardial Infarction (STEMI).
    Budiman T; Snodgrass K; Komatsu Chang A
    Ann Pharmacother; 2016 Feb; 50(2):118-24. PubMed ID: 26681443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improving 30-day readmissions: Student pharmacists' role in transitions of care.
    Kelsh S; de Voest M; Stout M
    J Am Pharm Assoc (2003); 2021; 61(4):e233-e236. PubMed ID: 33812782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of Student Pharmacist-Led Transition-of-Care Services on 30-Day Hospital Readmissions at a University Call Center.
    Pham H; Gangoo-Dookhan T; Hale G; Perez A; Joseph T
    J Pharm Technol; 2023 Oct; 39(5):207-211. PubMed ID: 37745726
    [No Abstract]   [Full Text] [Related]  

  • 14. Evaluating Pharmacist-Led Heart Failure Transitions of Care Clinic: Impact of Analytic Approach on Readmission Rate Endpoints.
    Cheng-Lai A; Prlesi L; Murthy S; Bellin EY; Sinnett MJ; Goriacko P
    Curr Probl Cardiol; 2023 Feb; 48(2):101507. PubMed ID: 36402220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of a pharmacy-driven transitions-of-care program on postdischarge healthcare utilization at a national comprehensive cancer center.
    Nguyen PAA; Enwere E; Gautreaux S; Lin H; Tverdek F; Lu M; Cao H; Chase J; Roux R
    Am J Health Syst Pharm; 2018 Sep; 75(18):1386-1393. PubMed ID: 30065061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of a pharmacist-led multidisciplinary transitions-of-care pilot for patients at high risk of readmission.
    Jones CD; Anthony A; Klein MD; Shakowski C; Smith HK; Go A; Perica K; Patel H; Pell J; Pierce R
    J Am Pharm Assoc (2003); 2018; 58(5):554-560. PubMed ID: 30017370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of a structured pharmacist-delivered intervention for patients post-acute coronary syndromes on all-cause hospitalizations and cardiac-related hospital readmissions: a prospective quasi-experimental study.
    El Hajj MS; Kaddoura R; Abu Yousef SEA; Orabi B; Awaisu A; AlYafei S; Shami R; Mahfoud ZR
    Int J Clin Pharm; 2023 Jun; 45(3):630-640. PubMed ID: 36795303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of the population health inpatient Medicare Advantage pharmacist intervention on hospital readmissions: A quasi-experimental controlled study.
    Nguyen AT; Wisniewski J; Leang DW; Keller MS; Rosen S; Shane R; Pevnick JM
    J Manag Care Spec Pharm; 2023 Mar; 29(3):266-275. PubMed ID: 36840959
    [No Abstract]   [Full Text] [Related]  

  • 19. Impact of ambulatory care pharmacist intervention on 30-day readmission rates in high-risk transitions-of-care patients.
    Sutt AR; Alm R; Olson JL
    J Am Pharm Assoc (2003); 2023; 63(6):1694-1699. PubMed ID: 37169256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of Pharmacist Involvement in Heart Failure Transition of Care.
    Neu R; Leonard MA; Dehoorne ML; Scalia SJ; Kale-Pradhan PB; Giuliano CA
    Ann Pharmacother; 2020 Mar; 54(3):239-246. PubMed ID: 31602994
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.